These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 23429459)

  • 1. Use and predictors of oral complementary and alternative medicine by patients with inflammatory bowel disease: a population-based, case-control study.
    Koning M; Ailabouni R; Gearry RB; Frampton CM; Barclay ML
    Inflamm Bowel Dis; 2013; 19(4):767-78. PubMed ID: 23429459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complementary and alternative medicine in patients with inflammatory bowel disease: the results of a population-based inception cohort study (IBSEN).
    Opheim R; Hoivik ML; Solberg IC; Moum B;
    J Crohns Colitis; 2012 Apr; 6(3):345-53. PubMed ID: 22405172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of complementary and alternative medicine in patients with inflammatory bowel disease: results of a cross-sectional study in Norway.
    Opheim R; Bernklev T; Fagermoen MS; Cvancarova M; Moum B
    Scand J Gastroenterol; 2012 Dec; 47(12):1436-47. PubMed ID: 23003678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of adherence to therapy and complementary and alternative medicine use with demographic factors and disease phenotype in patients with inflammatory bowel disease.
    Lakatos PL; Czegledi Z; David G; Kispal Z; Kiss LS; Palatka K; Kristof T; Nagy F; Salamon A; Demeter P; Miheller P; Szamosi T; Banai J; Papp M; Bene L; Kovacs A; Racz I; Lakatos L
    J Crohns Colitis; 2010 Sep; 4(3):283-90. PubMed ID: 21122517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment adherence and use of complementary and alternative medicine in patients with inflammatory bowel disease].
    Lakatos L; Czeglédi Z; Dávid G; Kispál Z; Kiss LS; Palatka K; Kristóf T; Molnár T; Salamon A; Demeter P; Miheller P; Szamosi T; Banai J; Papp M; Bene L; Kovács A; Rácz I; Lakatos PL
    Orv Hetil; 2010 Feb; 151(7):250-8. PubMed ID: 20133244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional variations in the use of complementary and alternative medicines (CAM) for inflammatory bowel disease patients in Italy: an IG-IBD study.
    Bertomoro P; Renna S; Cottone M; Riegler G; Bossa F; Giglio L; Pastorelli L; Papi C; Castiglione F; Angelucci E; Pica R; Di Paolo MC; D'Incà R
    J Crohns Colitis; 2010 Sep; 4(3):291-300. PubMed ID: 21122518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of complementary and alternative medicine (CAM) use in patients with inflammatory bowel disease: perceived stress is a potential indicator for CAM use.
    Langhorst J; Anthonisen IB; Steder-Neukamm U; Luedtke R; Spahn G; Michalsen A; Dobos GJ
    Complement Ther Med; 2007 Mar; 15(1):30-7. PubMed ID: 17352969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in patients with inflammatory bowel disease: results from a German national survey.
    Langhorst J; Anthonisen IB; Steder-Neukamm U; Lüdtke R; Spahn G; Michalsen A; Dobos GJ
    Inflamm Bowel Dis; 2005 Mar; 11(3):287-95. PubMed ID: 15735435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of complementary and alternative medicine (CAM) in patients with inflammatory bowel disease (IBD): results from a German nationwide survey of 2019 compared to a previous survey of 2002.
    Bauer N; Kairey L; Schlee C; Uecker C; Öznur Ö; Langhorst J
    Scand J Gastroenterol; 2022 Oct; 57(10):1209-1215. PubMed ID: 35722930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Complementary and Alternative Medicine for Inflammatory Bowel Disease Is Associated with Worse Adherence to Conventional Therapy: The COMPLIANT Study.
    Nguyen GC; Croitoru K; Silverberg MS; Steinhart AH; Weizman AV
    Inflamm Bowel Dis; 2016 Jun; 22(6):1412-7. PubMed ID: 27120570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experiences of complementary and alternative medicine in patients with inflammatory bowel disease - a qualitative study.
    Lindberg A; Fossum B; Karlen P; Oxelmark L
    BMC Complement Altern Med; 2014 Oct; 14():407. PubMed ID: 25338541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between inflammatory bowel disease and periodontitis among Jordanians: a case-control study.
    Habashneh RA; Khader YS; Alhumouz MK; Jadallah K; Ajlouni Y
    J Periodontal Res; 2012 Jun; 47(3):293-8. PubMed ID: 22050539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High incidence of Crohn's disease in Canterbury, New Zealand: results of an epidemiologic study.
    Gearry RB; Richardson A; Frampton CM; Collett JA; Burt MJ; Chapman BA; Barclay ML
    Inflamm Bowel Dis; 2006 Oct; 12(10):936-43. PubMed ID: 17012964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation of complementary and alternative medicine use and its impact on medication adherence in inflammatory bowel disease.
    Weizman AV; Ahn E; Thanabalan R; Leung W; Croitoru K; Silverberg MS; Steinhart AH; Nguyen GC
    Aliment Pharmacol Ther; 2012 Feb; 35(3):342-9. PubMed ID: 22176478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complementary and Alternative Medicine Use in Children With Inflammatory Bowel Diseases: A Single-Center Survey.
    Serpico MR; Boyle BM; Kemper KJ; Kim SC
    J Pediatr Gastroenterol Nutr; 2016 Dec; 63(6):651-657. PubMed ID: 26960176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population-based cases control study of inflammatory bowel disease risk factors.
    Gearry RB; Richardson AK; Frampton CM; Dodgshun AJ; Barclay ML
    J Gastroenterol Hepatol; 2010 Feb; 25(2):325-33. PubMed ID: 20074146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rising Incidence of Inflammatory Bowel Disease in Canterbury, New Zealand.
    Su HY; Gupta V; Day AS; Gearry RB
    Inflamm Bowel Dis; 2016 Sep; 22(9):2238-44. PubMed ID: 27482976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COMPLEMENTARY AND ALTERNATIVE MEDICINE USE IN BRAZILIAN PATIENTS WITH INFLAMMATORY BOWEL DISEASE.
    Henriques DP; Oliveira RR; Vanni J; Lima HP; Otiti JV; Neves FRM; Hammerle MB; Sassaki LY; Zaltman C
    Arq Gastroenterol; 2022; 59(3):375-382. PubMed ID: 36102435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asthma Is Associated With Subsequent Development of Inflammatory Bowel Disease: A Population-based Case-Control Study.
    Kuenzig ME; Barnabe C; Seow CH; Eksteen B; Negron ME; Rezaie A; Panaccione R; Benchimol EI; Sadatsafavi M; Aviña-Zubieta JA; Kaplan GG
    Clin Gastroenterol Hepatol; 2017 Sep; 15(9):1405-1412.e3. PubMed ID: 28344063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive factors of complementary and alternative medicine use for patients with inflammatory bowel disease in Korea.
    Park DI; Cha JM; Kim HS; Park HJ; Shin JE; Hong SN; Hong SS; Kim WJ
    Complement Ther Med; 2014 Feb; 22(1):87-93. PubMed ID: 24559822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.